Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	Func.ensGene	Gene.ensGene	GeneDetail.ensGene	ExonicFunc.ensGene	AAChange.ensGene	Func.knownGene	Gene.knownGene	GeneDetail.knownGene	ExonicFunc.knownGene	AAChange.knownGene	esp6500siv2_all	1000g2015aug_all	ExAC_ALL	ExAC_AFR	ExAC_AMR	ExAC_EAS	ExAC_FIN	ExAC_NFE	ExAC_OTH	ExAC_SAS	avsnp147	SIFT_score	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_pred	LRT_score	LRT_pred	MutationTaster_score	MutationTaster_pred	MutationAssessor_score	MutationAssessor_pred	FATHMM_score	FATHMM_pred	PROVEAN_score	PROVEAN_pred	VEST3_score	CADD_raw	CADD_phred	DANN_score	fathmm-MKL_coding_score	fathmm-MKL_coding_pred	MetaSVM_score	MetaSVM_pred	MetaLR_score	MetaLR_pred	integrated_fitCons_score	integrated_confidence_value	GERP++_RS	phyloP7way_vertebrate	phyloP20way_mammalian	phastCons7way_vertebrate	phastCons20way_mammalian	SiPhy_29way_logOdds	dbscSNV_ADA_SCORE	dbscSNV_RF_SCORE	Interpro_domain	CLNALLELEID	CLNDN	CLNDISDB	CLNREVSTAT	CLNSIG	cosmic91	ICGC_Id	ICGC_Occurrence	gnomAD_genome_ALL	gnomAD_genome_AFR	gnomAD_genome_AMR	gnomAD_genome_ASJ	gnomAD_genome_EAS	gnomAD_genome_FIN	gnomAD_genome_NFE	gnomAD_genome_OTH	Gene	Otherinfo1	
9	133748283	133748283	C	T	exonic	ABL1	.	nonsynonymous SNV	ABL1:NM_005157:exon6:c.C944T:p.T315I,ABL1:NM_007313:exon6:c.C1001T:p.T334I	exonic	ENSG00000097007	.	nonsynonymous SNV	ENSG00000097007:ENST00000318560:exon6:c.C944T:p.T315I,ENSG00000097007:ENST00000372348:exon6:c.C1001T:p.T334I	exonic	ABL1	.	nonsynonymous SNV	ABL1:uc004bzv.3:exon6:c.C1001T:p.T334I,ABL1:uc004bzw.3:exon6:c.C944T:p.T315I	.	.	.	.	.	.	.	.	.	.	rs121913459	0.002	D	0.999	D	0.989	D	0.000	D	1	A	0.565	N	-0.02	T	-5.72	D	0.964	6.838	33	0.999	0.967	D	-0.417	T	0.314	T	0.707	0	6.04	0.871	0.935	0.992	0.992	19.583	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	27663	Chronic_myelogenous_leukemia|Lymphoblastic_leukemia,_acute,_with_lymphomatous_features|Leukemia,_Philadelphia_chromosome-positive,_resistant_to_imatinib	Human_Phenotype_Ontology:HP:0005506,MeSH:D015464,MedGen:C0023473,OMIM:608232,Orphanet:ORPHA521|MedGen:C1855472,OMIM:247640|MedGen:C4016396	no_assertion_criteria_provided	Pathogenic/Likely_pathogenic	ID=COSV59323790;OCCURENCE=66(haematopoietic_and_lymphoid_tissue),2(skin)	.	.	.	.	.	.	.	.	.	.	ABL1		
14	105246551	105246551	C	T	exonic	AKT1	.	nonsynonymous SNV	AKT1:NM_001014431:exon3:c.G49A:p.E17K,AKT1:NM_005163:exon3:c.G49A:p.E17K,AKT1:NM_001014432:exon4:c.G49A:p.E17K	exonic	ENSG00000142208	.	nonsynonymous SNV	ENSG00000142208:ENST00000554581:exon2:c.G49A:p.E17K,ENSG00000142208:ENST00000402615:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000407796:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000554848:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000555528:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000349310:exon4:c.G49A:p.E17K,ENSG00000142208:ENST00000555926:exon4:c.G49A:p.E17K	exonic	AKT1	.	nonsynonymous SNV	AKT1:uc001ypl.3:exon2:c.G49A:p.E17K,AKT1:uc001ypk.3:exon3:c.G49A:p.E17K,AKT1:uc001ypn.3:exon3:c.G49A:p.E17K,AKT1:uc010axa.3:exon3:c.G49A:p.E17K,AKT1:uc001ypm.3:exon4:c.G49A:p.E17K	.	.	8.427e-06	0	0	0	0	1.535e-05	0	0	rs121434592	0.01	D	1.0	D	1.0	D	0.000	D	1	D	2.175	M	1.17	T	-3.59	D	0.884	6.534	31	0.999	0.995	D	-0.641	T	0.222	T	0.707	0	4.61	0.871	0.852	0.858	0.955	16.176	.	.	Pleckstrin homology domain;Pleckstrin homology-like domain	29022	Neoplasm_of_ovary|Hepatocellular_carcinoma|Osteosarcoma|Transitional_cell_carcinoma_of_the_bladder|Lung_adenocarcinoma|Small_cell_lung_cancer|Non-small_cell_lung_cancer|Squamous_cell_lung_carcinoma|Neoplasm_of_the_breast|Neoplasm_of_the_thyroid_gland|Prostate_neoplasm|Neoplasm_of_the_large_intestine|Squamous_cell_carcinoma_of_the_head_and_neck|Malignant_melanoma_of_skin|Uterine_cervical_neoplasms|Meningeal_Neoplasms|Adenocarcinoma_of_prostate|Proteus_syndrome|Adenocarcinoma_of_stomach|Endometrial_Endometrioid_Adenocarcinoma,_Variant_with_Squamous_Differentiation|Carcinoma_of_colon|Breast_adenocarcinoma	Gene:6765,Human_Phenotype_Ontology:HP:0100615,MedGen:C0919267,OMIM:167000,SNOMED_CT:123843001|Human_Phenotype_Ontology:HP:0001402,MedGen:C2239176,OMIM:114550,Orphanet:ORPHA88673,SNOMED_CT:187769009,SNOMED_CT:25370001|Human_Phenotype_Ontology:HP:0002669,MeSH:D012516,MedGen:C0029463,OMIM:259500,Orphanet:ORPHA668,SNOMED_CT:21708004|Human_Phenotype_Ontology:HP:0006740,MedGen:C0279680|Human_Phenotype_Ontology:HP:0030078,MeSH:C538231,MedGen:C0152013|Human_Phenotype_Ontology:HP:0030357,MeSH:D055752,MedGen:C0149925,OMIM:182280,Orphanet:ORPHA70573|Human_Phenotype_Ontology:HP:0030358,MeSH:D002289,MedGen:C0007131,SNOMED_CT:254637007|Human_Phenotype_Ontology:HP:0030359,MedGen:C0149782|Human_Phenotype_Ontology:HP:0100013,MeSH:D001943,MedGen:C1458155,Orphanet:ORPHA180250,SNOMED_CT:126926005|Human_Phenotype_Ontology:HP:0100031,MeSH:D013964,MedGen:C0040136,Orphanet:ORPHA100087|Human_Phenotype_Ontology:HP:0100787,MeSH:D011471,MedGen:C0033578|Human_Phenotype_Ontology:HP:0100834,MeSH:D015179,MedGen:C0009404,SNOMED_CT:126837005|MeSH:C535575,MedGen:C1168401,OMIM:275355,Orphanet:ORPHA67037|MeSH:C562393,MedGen:C0151779,SNOMED_CT:93655004|MeSH:D002583,MedGen:CN236667|MeSH:D008577,MedGen:C0025284,Orphanet:ORPHA252025|MedGen:C0007112|MedGen:C0085261,OMIM:176920,Orphanet:ORPHA744,SNOMED_CT:23150001|MedGen:C0278701|MedGen:C0279763|MedGen:C0699790,OMIM:114500,SNOMED_CT:269533000|MedGen:C0858252,Orphanet:ORPHA213528	no_assertion_criteria_provided	Pathogenic/Likely_pathogenic	ID=COSV62571334;OCCURENCE=5(salivary_gland),262(breast),2(peritoneum),5(cervix),69(meninges),46(large_intestine),2(central_nervous_system),3(biliary_tract),5(ovary),15(bone),6(NS),3(stomach),7(haematopoietic_and_lymphoid_tissue),1(kidney),18(soft_tissue),22(urinary_tract),5(pancreas),58(skin),16(prostate),24(lung),27(thyroid),11(upper_aerodigestive_tract),1(thymus),31(endometrium)	MU10466	BRCA-EU|13|569|0.0228471,PACA-AU|1|391|0.00255754,COCA-CN|3|321|0.00934579,PBCA-DE|1|499|0.00200401,UCEC-US|9|531|0.0169492,SKCM-US|2|466|0.00429185,EOPC-DE|1|202|0.0049505,BRCA-UK|4|141|0.0283688,COAD-US|4|402|0.00995025,LUAD-US|2|516|0.00387597,STAD-US|1|439|0.0022779,LUSC-US|1|485|0.00206186,BLCA-US|1|411|0.00243309,PEME-CA|1|112|0.00892857,BRCA-US|26|1020|0.0254902,HNSC-US|1|508|0.0019685,CESC-US|3|289|0.0103806,BTCA-JP|1|239|0.0041841,PRAD-US|2|497|0.00402414,BRCA-KR|4|50|0.08,BLCA-CN|1|103|0.00970874,THCA-US|3|492|0.00609756	.	.	.	.	.	.	.	.	AKT1		
7	140453136	140453136	A	T	exonic	BRAF	.	nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic	ENSG00000157764	.	nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic	BRAF	.	nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	29000	Cystic_epithelial_invagination_containing_papillae_lined_by_columnar_epithelium|Neoplasm|Papillary_thyroid_carcinoma|Multiple_myeloma|Brainstem_glioma|Cutaneous_melanoma|Lung_adenocarcinoma|Non-small_cell_lung_cancer|Neoplasm_of_brain|Neoplasm_of_the_colon|Gastrointestinal_stroma_tumor|Neoplasm_of_the_large_intestine|Squamous_cell_carcinoma_of_the_head_and_neck|Papillary_renal_cell_carcinoma,_sporadic|Malignant_melanoma_of_skin|Glioblastoma|Ovarian_Neoplasms|Lung_cancer|Carcinoma_of_colon|Germ_cell_tumor,_nonseminomatous|Cardio-facio-cutaneous_syndrome|Astrocytoma,_low-grade,_somatic|not_provided	.|Human_Phenotype_Ontology:HP:0002664,MeSH:D009369,MedGen:C0027651,SNOMED_CT:108369006|Human_Phenotype_Ontology:HP:0002895,MeSH:C536915,MedGen:C0238463,Orphanet:ORPHA146,SNOMED_CT:255029007|Human_Phenotype_Ontology:HP:0006775,MeSH:D009101,MedGen:C0026764,OMIM:254500,Orphanet:ORPHA29073,SNOMED_CT:109989006,SNOMED_CT:55921005|Human_Phenotype_Ontology:HP:0010796,MedGen:C0677865|Human_Phenotype_Ontology:HP:0012056,MeSH:D008545,MedGen:C0025202|Human_Phenotype_Ontology:HP:0030078,MeSH:C538231,MedGen:C0152013|Human_Phenotype_Ontology:HP:0030358,MeSH:D002289,MedGen:C0007131,SNOMED_CT:254637007|Human_Phenotype_Ontology:HP:0030692,MeSH:D001932,MedGen:C0006118,SNOMED_CT:126952004|Human_Phenotype_Ontology:HP:0100273,MeSH:D003110,MedGen:C0009375|Human_Phenotype_Ontology:HP:0100723,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:ORPHA44890|Human_Phenotype_Ontology:HP:0100834,MeSH:D015179,MedGen:C0009404,SNOMED_CT:126837005|MeSH:C535575,MedGen:C1168401,OMIM:275355,Orphanet:ORPHA67037|MeSH:C538614,MedGen:C1336078|MeSH:C562393,MedGen:C0151779,SNOMED_CT:93655004|MeSH:D005909,MedGen:C0017636,Orphanet:ORPHA360,SNOMED_CT:63634009|MeSH:D010051,MedGen:CN236629|MedGen:C0684249,OMIM:211980,SNOMED_CT:187875007|MedGen:C0699790,OMIM:114500,SNOMED_CT:269533000|MedGen:C1266158|MedGen:C1275081,Orphanet:ORPHA1340,SNOMED_CT:403770008|MedGen:C2674727|MedGen:CN517202	criteria_provided,_single_submitter	Pathogenic	ID=COSV56056643;OCCURENCE=9(salivary_gland),20(breast),1(female_genital_tract_(site_indeterminate)),19(liver),2(oesophagus),4(genital_tract),6(adrenal_gland),3(meninges),5352(large_intestine),421(central_nervous_system),28(biliary_tract),1(pleura),261(ovary),37(bone),1038(NS),4(stomach),856(haematopoietic_and_lymphoid_tissue),9(urinary_tract),31(kidney),58(soft_tissue),23(pancreas),3(autonomic_ganglia),91(pituitary),5930(skin),3(prostate),158(lung),14413(thyroid),13(upper_aerodigestive_tract),12(testis),95(eye),10(small_intestine),3(endometrium)	MU62030	MELA-AU|57|183|0.311475,SKCA-BR|29|100|0.29,MALY-DE|1|241|0.00414938,LICA-FR|1|252|0.00396825,COCA-CN|10|321|0.0311526,PBCA-DE|7|499|0.0140281,SKCM-US|204|466|0.437768,CLLE-ES|1|510|0.00196078,COAD-US|46|402|0.114428,LUAD-US|9|516|0.0174419,BLCA-US|1|411|0.00243309,HNSC-US|1|508|0.0019685,GBM-US|5|388|0.0128866,THCA-CN|24|50|0.48,READ-US|1|143|0.00699301,LGG-US|1|508|0.0019685,KIRP-US|1|278|0.00359712,THCA-US|287|492|0.583333,THCA-SA|128|243|0.526749	.	.	.	.	.	.	.	.	BRAF		
7	55249071	55249071	C	T	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_005228:exon20:c.C2369T:p.T790M	exonic	ENSG00000146648	.	nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M	exonic	EGFR	.	nonsynonymous SNV	EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M	.	.	4.122e-05	9.63e-05	0	0	0	6e-05	0	0	rs121434569	0.003	D	1.0	D	1.0	D	0.000	D	1	A	1.17	L	0.24	T	-5.22	D	0.923	7.364	34	0.999	0.941	D	-0.467	T	0.317	T	0.653	0	5.92	0.871	0.935	0.982	0.986	18.872	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	31652	Non-small_cell_lung_cancer|Lung_cancer|Nonsmall_cell_lung_cancer,_resistance_to_tyrosine_kinase_inhibitor_in|EGFR-related_lung_cancer|Tyrosine_kinase_inhibitor_response|erlotinib_response_-_Efficacy|gefitinib_response_-_Efficacy	Human_Phenotype_Ontology:HP:0030358,MeSH:D002289,MedGen:C0007131,SNOMED_CT:254637007|MedGen:C0684249,OMIM:211980,SNOMED_CT:187875007|MedGen:C4016033|MedGen:CN130014|MedGen:CN225347|MedGen:CN236552|MedGen:CN236558	reviewed_by_expert_panel	drug_response	ID=COSV51765492;OCCURENCE=3(breast),1(large_intestine),1(central_nervous_system),10(biliary_tract),1(soft_tissue),376(lung),2(upper_aerodigestive_tract)	MU131799503	LUAD-US|2|516|0.00387597	9.688e-05	0.0002	0	0	0	0	6.668e-05	0	EGFR		
7	55259524	55259524	T	A	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_005228:exon21:c.T2582A:p.L861Q	exonic	ENSG00000146648	.	nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon20:c.T2447A:p.L816Q,ENSG00000146648:ENST00000275493:exon21:c.T2582A:p.L861Q,ENSG00000146648:ENST00000454757:exon21:c.T2423A:p.L808Q	exonic	EGFR	.	nonsynonymous SNV	EGFR:uc022ado.1:exon2:c.T287A:p.L96Q,EGFR:uc010kzg.2:exon20:c.T2447A:p.L816Q,EGFR:uc022adn.1:exon20:c.T2447A:p.L816Q,EGFR:uc003tqk.3:exon21:c.T2582A:p.L861Q,EGFR:uc011kco.2:exon21:c.T2423A:p.L808Q,EGFR:uc022adm.1:exon21:c.T2582A:p.L861Q	.	.	.	.	.	.	.	.	.	.	rs121913444	0.009	D	0.999	D	0.973	D	0.000	D	1	D	0.735	N	-1.59	D	-5.29	D	0.916	6.420	29.7	0.994	0.981	D	0.243	D	0.571	D	0.741	0	5.82	0.991	1.061	0.997	0.980	15.005	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	174254	Lung_adenocarcinoma|Non-small_cell_lung_cancer|Squamous_cell_lung_carcinoma|Tyrosine_kinase_inhibitor_response	Human_Phenotype_Ontology:HP:0030078,MeSH:C538231,MedGen:C0152013|Human_Phenotype_Ontology:HP:0030358,MeSH:D002289,MedGen:C0007131,SNOMED_CT:254637007|Human_Phenotype_Ontology:HP:0030359,MedGen:C0149782|MedGen:CN225347	no_assertion_criteria_provided	Pathogenic/Likely_pathogenic,_drug_response	ID=COSV51766344;OCCURENCE=2(large_intestine),2(central_nervous_system),1(pancreas),104(lung),1(upper_aerodigestive_tract)	MU1314224	LUAD-US|4|516|0.00775194,LUSC-US|2|485|0.00412371,GBM-US|1|388|0.00257732	.	.	.	.	.	.	.	.	EGFR		
7	55249005	55249005	G	T	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_005228:exon20:c.G2303T:p.S768I	exonic	ENSG00000146648	.	nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon19:c.G2168T:p.S723I,ENSG00000146648:ENST00000275493:exon20:c.G2303T:p.S768I,ENSG00000146648:ENST00000454757:exon20:c.G2144T:p.S715I	exonic	EGFR	.	nonsynonymous SNV	EGFR:uc022ado.1:exon1:c.G8T:p.S3I,EGFR:uc010kzg.2:exon19:c.G2168T:p.S723I,EGFR:uc022adn.1:exon19:c.G2168T:p.S723I,EGFR:uc003tqk.3:exon20:c.G2303T:p.S768I,EGFR:uc011kco.2:exon20:c.G2144T:p.S715I,EGFR:uc022adm.1:exon20:c.G2303T:p.S768I	.	.	.	.	.	.	.	.	.	.	rs121913465	0.002	D	1.0	D	0.999	D	0.000	D	1	D	1.995	M	-1.7	D	-4.84	D	0.845	6.143	28.4	0.996	0.987	D	0.454	D	0.698	D	0.653	0	5.85	0.917	1.048	0.999	0.992	18.727	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	54418	Carcinoma_of_esophagus|Non-small_cell_lung_cancer|Squamous_cell_lung_carcinoma	Human_Phenotype_Ontology:HP:0011459,MedGen:C0152018,Orphanet:ORPHA70482|Human_Phenotype_Ontology:HP:0030358,MeSH:D002289,MedGen:C0007131,SNOMED_CT:254637007|Human_Phenotype_Ontology:HP:0030359,MedGen:C0149782	criteria_provided,_single_submitter	Pathogenic	ID=COSV51768106;OCCURENCE=1(breast),1(oesophagus),1(adrenal_gland),2(central_nervous_system),1(prostate),55(lung)	MU131498245	LUAD-US|3|516|0.00581395,BRCA-US|1|1020|0.000980392	.	.	.	.	.	.	.	.	EGFR		
7	148508727	148508727	T	A	exonic	EZH2	.	nonsynonymous SNV	EZH2:NM_001203249:exon15:c.A1769T:p.Y590F,EZH2:NM_152998:exon15:c.A1805T:p.Y602F,EZH2:NM_001203247:exon16:c.A1922T:p.Y641F,EZH2:NM_001203248:exon16:c.A1895T:p.Y632F,EZH2:NM_004456:exon16:c.A1937T:p.Y646F	exonic	ENSG00000106462	.	nonsynonymous SNV	ENSG00000106462:ENST00000350995:exon15:c.A1805T:p.Y602F,ENSG00000106462:ENST00000476773:exon15:c.A1769T:p.Y590F,ENSG00000106462:ENST00000541220:exon15:c.A1769T:p.Y590F,ENSG00000106462:ENST00000320356:exon16:c.A1937T:p.Y646F,ENSG00000106462:ENST00000460911:exon16:c.A1922T:p.Y641F,ENSG00000106462:ENST00000478654:exon16:c.A1769T:p.Y590F,ENSG00000106462:ENST00000483967:exon16:c.A1895T:p.Y632F	exonic	EZH2	.	nonsynonymous SNV	EZH2:uc022aov.1:exon13:c.A1679T:p.Y560F,EZH2:uc003wfc.2:exon15:c.A1805T:p.Y602F,EZH2:uc011kug.2:exon15:c.A1769T:p.Y590F,EZH2:uc003wfb.2:exon16:c.A1937T:p.Y646F,EZH2:uc003wfd.2:exon16:c.A1922T:p.Y641F,EZH2:uc011kuh.2:exon16:c.A1895T:p.Y632F	.	.	.	.	.	.	.	.	.	.	rs267601394	0.006	D	0.999	D	0.974	D	0.000	D	1	D	3.405	M	-1.9	D	-3.5	D	0.634	6.643	32	0.987	0.988	D	1.036	D	0.902	D	0.707	0	5.63	0.991	1.061	1.000	1.000	15.87	.	.	CXC domain;SET domain	87659	Lymphoma|Non-Hodgkin_lymphoma|Malignant_melanoma_of_skin	Human_Phenotype_Ontology:HP:0002665,MeSH:D008223,MedGen:C0024299,Orphanet:ORPHA223735|Human_Phenotype_Ontology:HP:0012539,MedGen:C0024305,OMIM:605027,Orphanet:ORPHA547,SNOMED_CT:1929004|MeSH:C562393,MedGen:C0151779,SNOMED_CT:93655004	no_assertion_criteria_provided	Likely_pathogenic	ID=COSV57445929;OCCURENCE=1(bone),89(haematopoietic_and_lymphoid_tissue),2(skin)	MU1372972	MALY-DE|10|241|0.0414938,SKCM-US|1|466|0.00214592,BOCA-FR|1|98|0.0102041	.	.	.	.	.	.	.	.	EZH2		
7	148508728	148508728	A	G	exonic	EZH2	.	nonsynonymous SNV	EZH2:NM_001203249:exon15:c.T1768C:p.Y590H,EZH2:NM_152998:exon15:c.T1804C:p.Y602H,EZH2:NM_001203247:exon16:c.T1921C:p.Y641H,EZH2:NM_001203248:exon16:c.T1894C:p.Y632H,EZH2:NM_004456:exon16:c.T1936C:p.Y646H	exonic	ENSG00000106462	.	nonsynonymous SNV	ENSG00000106462:ENST00000350995:exon15:c.T1804C:p.Y602H,ENSG00000106462:ENST00000476773:exon15:c.T1768C:p.Y590H,ENSG00000106462:ENST00000541220:exon15:c.T1768C:p.Y590H,ENSG00000106462:ENST00000320356:exon16:c.T1936C:p.Y646H,ENSG00000106462:ENST00000460911:exon16:c.T1921C:p.Y641H,ENSG00000106462:ENST00000478654:exon16:c.T1768C:p.Y590H,ENSG00000106462:ENST00000483967:exon16:c.T1894C:p.Y632H	exonic	EZH2	.	nonsynonymous SNV	EZH2:uc022aov.1:exon13:c.T1678C:p.Y560H,EZH2:uc003wfc.2:exon15:c.T1804C:p.Y602H,EZH2:uc011kug.2:exon15:c.T1768C:p.Y590H,EZH2:uc003wfb.2:exon16:c.T1936C:p.Y646H,EZH2:uc003wfd.2:exon16:c.T1921C:p.Y641H,EZH2:uc011kuh.2:exon16:c.T1894C:p.Y632H	.	.	.	.	.	.	.	.	.	.	rs267601395	0.0	D	1.0	D	0.991	D	0.000	D	1	D	4.605	H	-1.98	D	-4.31	D	0.956	6.744	32	0.998	0.992	D	1.102	D	0.945	D	0.707	0	5.52	1.062	1.199	1.000	1.000	15.677	.	.	CXC domain;SET domain	87660	Lymphoma|Non-Hodgkin_lymphoma|Malignant_melanoma_of_skin	Human_Phenotype_Ontology:HP:0002665,MeSH:D008223,MedGen:C0024299,Orphanet:ORPHA223735|Human_Phenotype_Ontology:HP:0012539,MedGen:C0024305,OMIM:605027,Orphanet:ORPHA547,SNOMED_CT:1929004|MeSH:C562393,MedGen:C0151779,SNOMED_CT:93655004	no_assertion_criteria_provided	Likely_pathogenic	ID=COSV57445793;OCCURENCE=1(salivary_gland),1(breast),1(biliary_tract),3(bone),27(haematopoietic_and_lymphoid_tissue),2(skin)	MU28727144	SKCA-BR|1|100|0.01,MALY-DE|2|241|0.00829876,BOCA-FR|1|98|0.0102041	.	.	.	.	.	.	.	.	EZH2		
7	148508728	148508728	A	T	exonic	EZH2	.	nonsynonymous SNV	EZH2:NM_001203249:exon15:c.T1768A:p.Y590N,EZH2:NM_152998:exon15:c.T1804A:p.Y602N,EZH2:NM_001203247:exon16:c.T1921A:p.Y641N,EZH2:NM_001203248:exon16:c.T1894A:p.Y632N,EZH2:NM_004456:exon16:c.T1936A:p.Y646N	exonic	ENSG00000106462	.	nonsynonymous SNV	ENSG00000106462:ENST00000350995:exon15:c.T1804A:p.Y602N,ENSG00000106462:ENST00000476773:exon15:c.T1768A:p.Y590N,ENSG00000106462:ENST00000541220:exon15:c.T1768A:p.Y590N,ENSG00000106462:ENST00000320356:exon16:c.T1936A:p.Y646N,ENSG00000106462:ENST00000460911:exon16:c.T1921A:p.Y641N,ENSG00000106462:ENST00000478654:exon16:c.T1768A:p.Y590N,ENSG00000106462:ENST00000483967:exon16:c.T1894A:p.Y632N	exonic	EZH2	.	nonsynonymous SNV	EZH2:uc022aov.1:exon13:c.T1678A:p.Y560N,EZH2:uc003wfc.2:exon15:c.T1804A:p.Y602N,EZH2:uc011kug.2:exon15:c.T1768A:p.Y590N,EZH2:uc003wfb.2:exon16:c.T1936A:p.Y646N,EZH2:uc003wfd.2:exon16:c.T1921A:p.Y641N,EZH2:uc011kuh.2:exon16:c.T1894A:p.Y632N	.	.	.	.	.	.	.	.	.	.	.	0.0	D	0.999	D	0.982	D	0.000	D	1	D	4.605	H	-1.98	D	-7.74	D	0.896	6.764	32	0.985	0.992	D	1.102	D	0.944	D	0.707	0	5.52	1.062	1.199	1.000	1.000	15.677	.	.	CXC domain;SET domain	363096	Lymphoma|Non-Hodgkin_lymphoma|Malignant_melanoma_of_skin	Human_Phenotype_Ontology:HP:0002665,MeSH:D008223,MedGen:C0024299,Orphanet:ORPHA223735|Human_Phenotype_Ontology:HP:0012539,MedGen:C0024305,OMIM:605027,Orphanet:ORPHA547,SNOMED_CT:1929004|MeSH:C562393,MedGen:C0151779,SNOMED_CT:93655004	no_assertion_criteria_provided	Likely_pathogenic	ID=COSV57445823;OCCURENCE=3(parathyroid),1(NS),79(haematopoietic_and_lymphoid_tissue),7(skin)	MU1477994	MELA-AU|1|183|0.00546448,SKCA-BR|1|100|0.01,MALY-DE|15|241|0.0622407,SKCM-US|2|466|0.00429185	.	.	.	.	.	.	.	.	EZH2		
7	148508727	148508727	T	G	exonic	EZH2	.	nonsynonymous SNV	EZH2:NM_001203249:exon15:c.A1769C:p.Y590S,EZH2:NM_152998:exon15:c.A1805C:p.Y602S,EZH2:NM_001203247:exon16:c.A1922C:p.Y641S,EZH2:NM_001203248:exon16:c.A1895C:p.Y632S,EZH2:NM_004456:exon16:c.A1937C:p.Y646S	exonic	ENSG00000106462	.	nonsynonymous SNV	ENSG00000106462:ENST00000350995:exon15:c.A1805C:p.Y602S,ENSG00000106462:ENST00000476773:exon15:c.A1769C:p.Y590S,ENSG00000106462:ENST00000541220:exon15:c.A1769C:p.Y590S,ENSG00000106462:ENST00000320356:exon16:c.A1937C:p.Y646S,ENSG00000106462:ENST00000460911:exon16:c.A1922C:p.Y641S,ENSG00000106462:ENST00000478654:exon16:c.A1769C:p.Y590S,ENSG00000106462:ENST00000483967:exon16:c.A1895C:p.Y632S	exonic	EZH2	.	nonsynonymous SNV	EZH2:uc022aov.1:exon13:c.A1679C:p.Y560S,EZH2:uc003wfc.2:exon15:c.A1805C:p.Y602S,EZH2:uc011kug.2:exon15:c.A1769C:p.Y590S,EZH2:uc003wfb.2:exon16:c.A1937C:p.Y646S,EZH2:uc003wfd.2:exon16:c.A1922C:p.Y641S,EZH2:uc011kuh.2:exon16:c.A1895C:p.Y632S	.	.	.	.	.	.	.	.	.	.	.	0.016	D	0.993	D	0.7	P	0.000	D	1	D	4.605	H	-1.94	D	-7.77	D	0.992	6.692	32	0.991	0.989	D	1.083	D	0.923	D	0.707	0	5.63	0.991	1.061	1.000	1.000	15.87	.	.	CXC domain;SET domain	363097	Lymphoma|Non-Hodgkin_lymphoma|Malignant_melanoma_of_skin	Human_Phenotype_Ontology:HP:0002665,MeSH:D008223,MedGen:C0024299,Orphanet:ORPHA223735|Human_Phenotype_Ontology:HP:0012539,MedGen:C0024305,OMIM:605027,Orphanet:ORPHA547,SNOMED_CT:1929004|MeSH:C562393,MedGen:C0151779,SNOMED_CT:93655004	no_assertion_criteria_provided	Likely_pathogenic	ID=COSV57446054;OCCURENCE=42(haematopoietic_and_lymphoid_tissue),2(skin)	MU1634230	MELA-AU|1|183|0.00546448,MALY-DE|6|241|0.0248963	.	.	.	.	.	.	.	.	EZH2		
4	1803564	1803564	C	T	exonic	FGFR3	.	nonsynonymous SNV	FGFR3:NM_000142:exon7:c.C742T:p.R248C,FGFR3:NM_001163213:exon7:c.C742T:p.R248C,FGFR3:NM_022965:exon7:c.C742T:p.R248C	exonic	ENSG00000068078	.	nonsynonymous SNV	ENSG00000068078:ENST00000507588:exon3:c.C202T:p.R68C,ENSG00000068078:ENST00000260795:exon6:c.C742T:p.R248C,ENSG00000068078:ENST00000352904:exon6:c.C742T:p.R248C,ENSG00000068078:ENST00000340107:exon7:c.C742T:p.R248C,ENSG00000068078:ENST00000412135:exon7:c.C742T:p.R248C,ENSG00000068078:ENST00000440486:exon7:c.C742T:p.R248C,ENSG00000068078:ENST00000481110:exon7:c.C742T:p.R248C	exonic	FGFR3	.	nonsynonymous SNV	FGFR3:uc003gdt.1:exon3:c.C268T:p.R90C,FGFR3:uc010icb.1:exon3:c.C268T:p.R90C,FGFR3:uc003gdq.3:exon7:c.C742T:p.R248C,FGFR3:uc003gdr.3:exon7:c.C742T:p.R248C,FGFR3:uc003gds.3:exon7:c.C742T:p.R248C,FGFR3:uc003gdu.2:exon7:c.C742T:p.R248C	.	.	.	.	.	.	.	.	.	.	rs121913482	0.05	D	1.0	D	0.999	D	0.000	N	1	A	4.01	H	-1.37	T	-6.69	D	0.872	6.430	29.7	0.999	0.847	D	0.938	D	0.799	D	0.696	0	3.0	-0.058	0.721	0.938	0.935	13.581	.	.	Immunoglobulin-like fold	31371	Short_ribs|Narrow_chest|Growth_delay|Small_for_gestational_age|Bell-shaped_thorax|Skeletal_dysplasia|Femoral_bowing|Bowed_humerus|Short_stature|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Disproportionate_short-limb_short_stature|Lethal_short-limbed_short_stature|Lower_limb_undergrowth|Upper_limb_undergrowth|Epidermal_nevus|Lung_adenocarcinoma|Squamous_cell_lung_carcinoma|Carcinoma|Squamous_cell_carcinoma_of_the_head_and_neck|Achondroplasia|Keratosis,_seborrheic|Skeletal_dysplasia_with_acanthosis_nigricans|Thanatophoric_dysplasia_type_1|not_provided	Human_Phenotype_Ontology:HP:0000773,MedGen:C0426817|Human_Phenotype_Ontology:HP:0000774,MedGen:C0426790|Human_Phenotype_Ontology:HP:0001510,MedGen:C0456070|Human_Phenotype_Ontology:HP:0001518,MedGen:C0235991|Human_Phenotype_Ontology:HP:0001591,MedGen:C1865186|Human_Phenotype_Ontology:HP:0002652,MedGen:C0410528,SNOMED_CT:105986008|Human_Phenotype_Ontology:HP:0002980,MedGen:C1859461|Human_Phenotype_Ontology:HP:0003865,MedGen:C1859460|Human_Phenotype_Ontology:HP:0004322,MedGen:C0349588|Human_Phenotype_Ontology:HP:0006740,MedGen:C0279680|Human_Phenotype_Ontology:HP:0006775,MeSH:D009101,MedGen:C0026764,OMIM:254500,Orphanet:ORPHA29073,SNOMED_CT:109989006,SNOMED_CT:55921005|Human_Phenotype_Ontology:HP:0008873,MedGen:C1849937|Human_Phenotype_Ontology:HP:0008909,MedGen:C2674171|Human_Phenotype_Ontology:HP:0009816,MedGen:C0345371|Human_Phenotype_Ontology:HP:0009824,MedGen:C1837406|Human_Phenotype_Ontology:HP:0010816,MedGen:C0334082,OMIM:162900,Orphanet:ORPHA35125,SNOMED_CT:25201003|Human_Phenotype_Ontology:HP:0030078,MeSH:C538231,MedGen:C0152013|Human_Phenotype_Ontology:HP:0030359,MedGen:C0149782|Human_Phenotype_Ontology:HP:0030731,MeSH:D002277,MedGen:C0007097|MeSH:C535575,MedGen:C1168401,OMIM:275355,Orphanet:ORPHA67037|MedGen:C0001080,OMIM:100800,Orphanet:ORPHA15,SNOMED_CT:86268005|MedGen:C0022603,OMIM:182000|MedGen:C1851152|MedGen:C1868678,OMIM:187600,Orphanet:ORPHA1860|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Pathogenic	ID=COSV53390662;OCCURENCE=1(breast),2(haematopoietic_and_lymphoid_tissue),215(urinary_tract),73(skin),3(lung),4(upper_aerodigestive_tract)	MU1296398	LUSC-KR|2|170|0.0117647,LUSC-US|1|485|0.00206186,BLCA-US|3|411|0.00729927,HNSC-US|1|508|0.0019685,BLCA-CN|4|103|0.038835	.	.	.	.	.	.	.	.	FGFR3		
4	1803568	1803568	C	G	exonic	FGFR3	.	nonsynonymous SNV	FGFR3:NM_000142:exon7:c.C746G:p.S249C,FGFR3:NM_001163213:exon7:c.C746G:p.S249C,FGFR3:NM_022965:exon7:c.C746G:p.S249C	exonic	ENSG00000068078	.	nonsynonymous SNV	ENSG00000068078:ENST00000507588:exon3:c.C206G:p.S69C,ENSG00000068078:ENST00000260795:exon6:c.C746G:p.S249C,ENSG00000068078:ENST00000352904:exon6:c.C746G:p.S249C,ENSG00000068078:ENST00000340107:exon7:c.C746G:p.S249C,ENSG00000068078:ENST00000412135:exon7:c.C746G:p.S249C,ENSG00000068078:ENST00000440486:exon7:c.C746G:p.S249C,ENSG00000068078:ENST00000481110:exon7:c.C746G:p.S249C	exonic	FGFR3	.	nonsynonymous SNV	FGFR3:uc003gdt.1:exon3:c.C272G:p.S91C,FGFR3:uc010icb.1:exon3:c.C272G:p.S91C,FGFR3:uc003gdq.3:exon7:c.C746G:p.S249C,FGFR3:uc003gdr.3:exon7:c.C746G:p.S249C,FGFR3:uc003gds.3:exon7:c.C746G:p.S249C,FGFR3:uc003gdu.2:exon7:c.C746G:p.S249C	.	.	9.654e-06	0	0	0	0	1.777e-05	0	0	rs121913483	0.045	D	1.0	D	0.994	D	0.000	D	1	A	3.305	M	-1.32	T	-4.17	D	0.877	3.567	23.1	0.988	0.962	D	0.799	D	0.771	D	0.696	0	3.94	0.871	0.721	0.991	0.928	16.288	.	.	.	31378	Bladder_carcinoma|Transitional_cell_carcinoma_of_the_bladder|Squamous_cell_lung_carcinoma|Carcinoma|Squamous_cell_carcinoma_of_the_head_and_neck|Papillary_renal_cell_carcinoma,_sporadic|Bladder_cancer,_somatic|Keratosis,_seborrheic|Carcinoma_of_cervix|Thanatophoric_dysplasia_type_1|not_provided	Human_Phenotype_Ontology:HP:0002862,MedGen:C0699885|Human_Phenotype_Ontology:HP:0006740,MedGen:C0279680|Human_Phenotype_Ontology:HP:0030359,MedGen:C0149782|Human_Phenotype_Ontology:HP:0030731,MeSH:D002277,MedGen:C0007097|MeSH:C535575,MedGen:C1168401,OMIM:275355,Orphanet:ORPHA67037|MeSH:C538614,MedGen:C1336078|MedGen:C0005684,OMIM:109800,Orphanet:ORPHA157980,SNOMED_CT:399326009|MedGen:C0022603,OMIM:182000|MedGen:C0302592,OMIM:603956,SNOMED_CT:285432005|MedGen:C1868678,OMIM:187600,Orphanet:ORPHA1860|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Pathogenic	ID=COSV53390026;OCCURENCE=7(cervix),3(vulva),3(ovary),1438(urinary_tract),27(skin),7(lung),24(upper_aerodigestive_tract),2(thymus)	MU1305116	LUSC-US|4|485|0.00824742,BLCA-US|33|411|0.080292,HNSC-US|4|508|0.00787402,BLCA-CN|3|103|0.0291262	.	.	.	.	.	.	.	.	FGFR3		
4	1806099	1806099	A	G	exonic	FGFR3	.	nonsynonymous SNV	FGFR3:NM_000142:exon9:c.A1118G:p.Y373C,FGFR3:NM_001163213:exon9:c.A1124G:p.Y375C	exonic	ENSG00000068078	.	nonsynonymous SNV	ENSG00000068078:ENST00000260795:exon8:c.A1118G:p.Y373C,ENSG00000068078:ENST00000340107:exon9:c.A1124G:p.Y375C,ENSG00000068078:ENST00000440486:exon9:c.A1118G:p.Y373C,ENSG00000068078:ENST00000481110:exon9:c.A1118G:p.Y373C	exonic	FGFR3	.	nonsynonymous SNV	FGFR3:uc003gdq.3:exon9:c.A1118G:p.Y373C,FGFR3:uc003gdr.3:exon9:c.A1118G:p.Y373C,FGFR3:uc003gdu.2:exon9:c.A1124G:p.Y375C	.	.	.	.	.	.	.	.	.	.	rs121913485	0.003	D	0.999	D	0.978	D	0.008	N	1	A	2.595	M	-2.35	D	-6.0	D	0.916	3.448	23.0	0.993	0.979	D	0.732	D	0.782	D	0.696	0	1.93	0.042	1.194	0.944	0.948	8.987	.	.	.	31381	Bladder_carcinoma|Myeloproliferative_disorder|Transitional_cell_carcinoma_of_the_bladder|Carcinoma|Papillary_renal_cell_carcinoma,_sporadic|Thanatophoric_dysplasia_type_1|not_provided	Human_Phenotype_Ontology:HP:0002862,MedGen:C0699885|Human_Phenotype_Ontology:HP:0005547,MeSH:D009196,MedGen:C0027022,SNOMED_CT:425333006|Human_Phenotype_Ontology:HP:0006740,MedGen:C0279680|Human_Phenotype_Ontology:HP:0030731,MeSH:D002277,MedGen:C0007097|MeSH:C538614,MedGen:C1336078|MedGen:C1868678,OMIM:187600,Orphanet:ORPHA1860|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Pathogenic	ID=COSV53390174;OCCURENCE=1(biliary_tract),8(haematopoietic_and_lymphoid_tissue),2(kidney),446(urinary_tract),16(skin),1(upper_aerodigestive_tract),1(thymus)	MU4618837	BLCA-US|8|411|0.0194647,KIRP-US|2|278|0.00719424,BLCA-CN|6|103|0.0582524	.	.	.	.	.	.	.	.	FGFR3		
9	5073770	5073770	G	T	exonic	JAK2	.	nonsynonymous SNV	JAK2:NM_004972:exon14:c.G1849T:p.V617F	exonic	ENSG00000096968	.	nonsynonymous SNV	ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F	exonic	JAK2	.	nonsynonymous SNV	JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F	0.0002	.	0.0007	0.0006	0.0003	0.0006	0.0005	0.0008	0	0.0005	rs77375493	0.002	D	0.996	D	0.934	D	0.000	D	1	D	2	M	-1.69	D	-3.86	D	0.94	6.874	33	0.995	0.945	D	0.442	D	0.681	D	0.653	0	5.51	0.917	0.980	1.000	1.000	19.407	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	29701	Budd-Chiari_syndrome,_susceptibility_to,_somatic|Budd-Chiari_syndrome|Acute_myeloid_leukemia|Chronic_myelogenous_leukemia|Myeloproliferative_disorder|Myelofibrosis|Polycythemia_vera|Subacute_lymphoid_leukemia|Familial_erythrocytosis,_1|Thrombocythemia_3	.|Human_Phenotype_Ontology:HP:0002639,MedGen:C0856761,OMIM:600880,Orphanet:ORPHA131,SNOMED_CT:82385007|Human_Phenotype_Ontology:HP:0004808,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:ORPHA519,SNOMED_CT:17788007|Human_Phenotype_Ontology:HP:0005506,MeSH:D015464,MedGen:C0023473,OMIM:608232,Orphanet:ORPHA521|Human_Phenotype_Ontology:HP:0005547,MeSH:D009196,MedGen:C0027022,SNOMED_CT:425333006|Human_Phenotype_Ontology:HP:0011974,MeSH:D055728,MedGen:C0001815,OMIM:254450|MeSH:D011087,MedGen:C0032463,OMIM:263300,Orphanet:ORPHA729|MedGen:C0152271|MedGen:C1851490,OMIM:133100|MedGen:C3281125,OMIM:614521	criteria_provided,_multiple_submitters,_no_conflicts	Pathogenic	ID=COSV67569051;OCCURENCE=1(liver),1(central_nervous_system),1(NS),41923(haematopoietic_and_lymphoid_tissue),3(lung),1(thyroid)	MU599827	LAML-KR|4|205|0.0195122,LIHC-US|1|364|0.00274725,LAML-CN|1|81|0.0123457,AML-US|1|166|0.0060241	0.0002	0.0002	0	0	0.0006	0.0003	0.0002	0	JAK2		
4	55602664	55602664	G	C	exonic	KIT	.	nonsynonymous SNV	KIT:NM_000222:exon18:c.G2485C:p.A829P,KIT:NM_001093772:exon18:c.G2473C:p.A825P	exonic	ENSG00000157404	.	nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon18:c.G2485C:p.A829P,ENSG00000157404:ENST00000412167:exon18:c.G2473C:p.A825P	exonic	KIT	.	nonsynonymous SNV	KIT:uc010igr.3:exon18:c.G2485C:p.A829P,KIT:uc010igs.3:exon18:c.G2473C:p.A825P	.	.	.	.	.	.	.	.	.	.	.	0.002	D	0.992	D	0.869	P	0.001	D	1	D	0.28	N	-2.5	D	-4.15	D	0.968	5.548	26.4	0.998	0.988	D	0.220	D	0.643	D	0.707	0	5.7	0.917	1.048	0.703	0.142	19.451	0.9990	0.954	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	362812	Cutaneous_melanoma|Gastrointestinal_stroma_tumor	Human_Phenotype_Ontology:HP:0012056,MeSH:D008545,MedGen:C0025202|Human_Phenotype_Ontology:HP:0100723,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:ORPHA44890	no_assertion_criteria_provided	Pathogenic/Likely_pathogenic	ID=COSV55414160;OCCURENCE=1(soft_tissue),1(genital_tract),3(testis)	.	.	.	.	.	.	.	.	.	.	KIT		
4	55595519	55595519	C	T	exonic	KIT	.	nonsynonymous SNV	KIT:NM_000222:exon14:c.C2009T:p.T670I,KIT:NM_001093772:exon14:c.C1997T:p.T666I	exonic	ENSG00000157404	.	nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon14:c.C2009T:p.T670I,ENSG00000157404:ENST00000412167:exon14:c.C1997T:p.T666I	exonic	KIT	.	nonsynonymous SNV	KIT:uc010igt.2:exon4:c.C356T:p.T119I,KIT:uc010igr.3:exon14:c.C2009T:p.T670I,KIT:uc010igs.3:exon14:c.C1997T:p.T666I	.	.	.	.	.	.	.	.	.	.	rs121913516	0.0	D	1.0	D	1.0	D	0.000	D	1	D	0.79	N	-2.53	D	-5.51	D	0.954	6.958	33	0.999	0.989	D	0.587	D	0.736	D	0.706	0	5.93	0.871	0.935	0.999	0.983	20.336	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	362937	Gastrointestinal_stroma_tumor	Human_Phenotype_Ontology:HP:0100723,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:ORPHA44890	no_assertion_criteria_provided	Likely_pathogenic	ID=COSV55410040;OCCURENCE=6(soft_tissue),2(skin)	.	.	3.23e-05	0	0	0	0	0.0003	0	0	KIT		
4	55594258	55594258	T	C	exonic	KIT	.	nonsynonymous SNV	KIT:NM_000222:exon13:c.T1961C:p.V654A,KIT:NM_001093772:exon13:c.T1949C:p.V650A	exonic	ENSG00000157404	.	nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon13:c.T1961C:p.V654A,ENSG00000157404:ENST00000412167:exon13:c.T1949C:p.V650A	exonic	KIT	.	nonsynonymous SNV	KIT:uc010igt.2:exon3:c.T308C:p.V103A,KIT:uc010igr.3:exon13:c.T1961C:p.V654A,KIT:uc010igs.3:exon13:c.T1949C:p.V650A	.	.	.	.	.	.	.	.	.	.	rs121913523	0.021	D	0.789	P	0.741	P	0.000	D	1	D	2.285	M	-3.11	D	-3.68	D	0.858	5.700	26.8	0.999	0.953	D	0.818	D	0.836	D	0.706	0	6.06	0.991	1.061	0.997	0.995	16.609	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain;Tyrosine-protein kinase, receptor class III, conserved site	362800	Cutaneous_melanoma|Gastrointestinal_stroma_tumor	Human_Phenotype_Ontology:HP:0012056,MeSH:D008545,MedGen:C0025202|Human_Phenotype_Ontology:HP:0100723,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:ORPHA44890	no_assertion_criteria_provided	Pathogenic/Likely_pathogenic	ID=COSV55389496;OCCURENCE=1(haematopoietic_and_lymphoid_tissue),46(soft_tissue)	MU55852071	MELA-AU|1|183|0.00546448	.	.	.	.	.	.	.	.	KIT		
4	55599341	55599341	T	G	exonic	KIT	.	nonsynonymous SNV	KIT:NM_000222:exon17:c.T2467G:p.Y823D,KIT:NM_001093772:exon17:c.T2455G:p.Y819D	exonic	ENSG00000157404	.	nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon17:c.T2467G:p.Y823D,ENSG00000157404:ENST00000412167:exon17:c.T2455G:p.Y819D	exonic	KIT	.	nonsynonymous SNV	KIT:uc010igr.3:exon17:c.T2467G:p.Y823D,KIT:uc010igs.3:exon17:c.T2455G:p.Y819D	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	0.000	D	1	D	2.105	M	-1.86	D	-8.45	D	0.977	6.923	33	0.989	0.998	D	0.588	D	0.728	D	0.707	0	5.47	0.991	1.011	1.000	1.000	15.549	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	362980	Gastrointestinal_stroma_tumor	Human_Phenotype_Ontology:HP:0100723,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:ORPHA44890	no_assertion_criteria_provided	Likely_pathogenic	ID=COSV55388545;OCCURENCE=1(genital_tract),1(large_intestine),1(haematopoietic_and_lymphoid_tissue),7(soft_tissue),11(testis)	.	.	.	.	.	.	.	.	.	.	KIT		
4	55599321	55599321	A	T	exonic	KIT	.	nonsynonymous SNV	KIT:NM_000222:exon17:c.A2447T:p.D816V,KIT:NM_001093772:exon17:c.A2435T:p.D812V	exonic	ENSG00000157404	.	nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon17:c.A2447T:p.D816V,ENSG00000157404:ENST00000412167:exon17:c.A2435T:p.D812V	exonic	KIT	.	nonsynonymous SNV	KIT:uc010igr.3:exon17:c.A2447T:p.D816V,KIT:uc010igs.3:exon17:c.A2435T:p.D812V	.	.	.	.	.	.	.	.	.	.	rs121913507	0.0	D	0.998	D	0.961	D	0.000	D	1	A	0.63	N	-1.74	D	-7.53	D	0.99	6.511	31	0.994	0.991	D	0.303	D	0.562	D	0.707	0	5.62	1.062	1.140	1.000	1.000	15.813	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	28891	MAST_CELL_LEUKEMIA,_SOMATIC|MASTOCYTOSIS_WITH_ASSOCIATED_HEMATOLOGIC_DISORDER,_SOMATIC|MASTOCYTOSIS,_SYSTEMIC,_SOMATIC|Hematologic_neoplasm|Acute_myeloid_leukemia|Dysgerminoma|Gastrointestinal_stroma_tumor|Cutaneous_mastocytosis|Mast_cell_leukemia	.|.|.|Human_Phenotype_Ontology:HP:0004377,MeSH:D019337,MedGen:C0376545,SNOMED_CT:129154003|Human_Phenotype_Ontology:HP:0004808,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:ORPHA519,SNOMED_CT:17788007|Human_Phenotype_Ontology:HP:0100621,MedGen:C0013377|Human_Phenotype_Ontology:HP:0100723,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:ORPHA44890|Human_Phenotype_Ontology:HP:0200151,MedGen:C1136033,Orphanet:ORPHA66646|MeSH:D007946,MedGen:C0023461,Orphanet:ORPHA98851	criteria_provided,_single_submitter	Uncertain_significance	ID=COSV55386424;OCCURENCE=6(genital_tract),1(cervix),6(ovary),1(NS),814(haematopoietic_and_lymphoid_tissue),3(skin),22(testis)	MU820931	SKCA-BR|1|100|0.01,LAML-KR|3|205|0.0146341,CESC-US|1|289|0.00346021,LAML-US|2|139|0.0143885,AML-US|3|166|0.0180723	.	.	.	.	.	.	.	.	KIT		
12	25398285	25398285	C	A	exonic	KRAS	.	nonsynonymous SNV	KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C	exonic	ENSG00000133703	.	nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C	exonic	KRAS	.	nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C	.	.	1.976e-05	0	0	0.0001	0	1.873e-05	0	0	rs121913530	0.02	D	1.0	D	0.993	D	0.000	D	1	D	3.135	M	-1.24	T	-6.99	D	0.905	7.016	33	0.997	0.984	D	0.548	D	0.701	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	27617	Endometrial_carcinoma|Lung_adenocarcinoma|Non-small_cell_lung_cancer|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine|Ovarian_Neoplasms|Lung_cancer	Human_Phenotype_Ontology:HP:0012114,MedGen:C0476089,OMIM:608089,SNOMED_CT:254878006|Human_Phenotype_Ontology:HP:0030078,MeSH:C538231,MedGen:C0152013|Human_Phenotype_Ontology:HP:0030358,MeSH:D002289,MedGen:C0007131,SNOMED_CT:254637007|Human_Phenotype_Ontology:HP:0100031,MeSH:D013964,MedGen:C0040136,Orphanet:ORPHA100087|Human_Phenotype_Ontology:HP:0100834,MeSH:D015179,MedGen:C0009404,SNOMED_CT:126837005|MeSH:D010051,MedGen:CN236629|MedGen:C0684249,OMIM:211980,SNOMED_CT:187875007	no_assertion_criteria_provided	Pathogenic/Likely_pathogenic	ID=COSV55497469;OCCURENCE=13(breast),2(penis),7(liver),11(peritoneum),3(oesophagus),1(genital_tract),1(adrenal_gland),8(cervix),2065(large_intestine),1(central_nervous_system),66(biliary_tract),46(ovary),20(NS),29(haematopoietic_and_lymphoid_tissue),18(stomach),18(urinary_tract),18(soft_tissue),5(kidney),190(pancreas),4(gastrointestinal_tract_(site_indeterminate)),8(skin),10(prostate),2607(lung),20(thyroid),9(upper_aerodigestive_tract),4(testis),19(small_intestine),63(endometrium)	MU22774	ESAD-UK|3|409|0.00733496,PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,PACA-AU|6|391|0.0153453,COCA-CN|8|321|0.0249221,UCEC-US|6|531|0.0112994,SKCM-US|1|466|0.00214592,GACA-JP|1|585|0.0017094,COAD-US|10|402|0.0248756,LUAD-US|67|516|0.129845,STAD-US|2|439|0.00455581,BLCA-US|2|411|0.00486618,BRCA-US|1|1020|0.000980392,CESC-US|2|289|0.00692042,BTCA-JP|1|239|0.0041841,LIHC-US|1|364|0.00274725,READ-US|7|143|0.048951,PAAD-US|1|177|0.00564972,KIRC-US|1|361|0.00277008,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	KRAS		
4	55152093	55152093	A	T	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:NM_006206:exon18:c.A2525T:p.D842V	exonic	ENSG00000134853;ENSG00000145216	.	nonsynonymous SNV	ENSG00000134853:ENST00000257290:exon18:c.A2525T:p.D842V,ENSG00000145216:ENST00000507166:exon19:c.A1805T:p.D602V	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:uc003han.4:exon18:c.A2525T:p.D842V,PDGFRA:uc003haa.3:exon19:c.A1805T:p.D602V	.	.	.	.	.	.	.	.	.	.	rs121908585	0.001	D	1.0	D	1.0	D	0.005	U	1	D	0.6	N	-1.74	D	-6.75	D	0.982	6.552	31	0.995	0.993	D	0.265	D	0.568	D	0.598	0	5.85	1.062	1.088	1.000	1.000	16.248	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	28582	Gastrointestinal_stroma_tumor	Human_Phenotype_Ontology:HP:0100723,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:ORPHA44890	no_assertion_criteria_provided	Pathogenic	ID=COSV57264120;OCCURENCE=2(large_intestine),1(central_nervous_system),1(haematopoietic_and_lymphoid_tissue),10(stomach),177(soft_tissue),4(small_intestine)	.	.	.	.	.	.	.	.	.	.	PDGFRA		
4	55152092	55152092	G	T	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:NM_006206:exon18:c.G2524T:p.D842Y	exonic	ENSG00000134853;ENSG00000145216	.	nonsynonymous SNV	ENSG00000134853:ENST00000257290:exon18:c.G2524T:p.D842Y,ENSG00000145216:ENST00000507166:exon19:c.G1804T:p.D602Y	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:uc003han.4:exon18:c.G2524T:p.D842Y,PDGFRA:uc003haa.3:exon19:c.G1804T:p.D602Y	.	.	.	.	.	.	.	.	.	.	rs121913265	0.011	D	1.0	D	1.0	D	0.005	U	1	D	0.95	L	-1.76	D	-6.69	D	0.967	7.212	34	0.996	0.994	D	0.289	D	0.625	D	0.598	0	6.04	0.917	1.048	1.000	1.000	20.579	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	363129	Gastrointestinal_stroma_tumor	Human_Phenotype_Ontology:HP:0100723,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:ORPHA44890	no_assertion_criteria_provided	Likely_pathogenic	ID=COSV57269122;OCCURENCE=2(central_nervous_system),3(soft_tissue)	MU81977161	PBCA-DE|1|499|0.00200401,GBM-US|1|388|0.00257732	.	.	.	.	.	.	.	.	PDGFRA		
